Abstract
Ocular ischemic syndrome is a clinical syndrome characterized by a series of insufficient blood supply-related brain and ocular symptoms caused by chronic severe carotid stenosis or occlusion, and atherosclerosis is the most common cause. Ocular ischemic syndrome, apart from its ocular ischemic sign, is often accompanied by hypertension and diabetes, peripheral vascular disease, and other systemic diseases, and 5-year mortality rate can be as high as 40%, with cardiovascular events being the most common cause of death. Therefore, prevention of more severe ischemic cardiovascular disease while reducing the impairment of visual function is particularly important. A multidisciplinary comprehensive diagnosis and treatment model, based on the complexity of integration, is the direction to solve the ocular ischemic syndrome problems. After reading this chapter, we can better understand the new concept of clinical multidisciplinary comprehensive diagnosis and treatment mode. In the case of ocular ischemic syndrome, the diagnosis and treatment should be discussed and made by ophthalmologist, neurologist, cardiologist, neurosurgeon, vascular surgeon, and interventional radiologist among other teams and departments together, so that the patients can get the best treatment and life-threatening systemic ischemic disease be avoided or reduced while the ophthalmologist is saving the visual acuity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wang YL. Basics of ocular ischemia syndrome. Diagnosis and treatment of ocular ischemia syndrome. Beijing: People’s Military Medical Press; 2012. p. 1–20.
Sivalingam A, Brown GC, Magargal LE, et al. The ocular ischemic syndrome: II: mortality and systemic morbidity. Int Ophthalmol. 1989;13:187–91.
Hollenhorst RW. Ocular manifestations of insufficiency or thrombosis of the internal carotid artery. Am J Ophthalmol. 1959;47:753–67.
Alizai AM, Trobe JD, Thompson BG, et al. Ocular ischemic syndrome after occlusion of both external carotid arteries. J Neuroophthalmol. 2005;25:268–72.
Kearns TP, Hollenhorst RW. Venous stasis retinopathy of occlusive disease of the carotid artery. Proc Staff Meet Mayo Clin. 1963;38:304–12.
Hedges TR Jr. Ophthalmoscopic findings in internal carotid artery occlusion. Bull Johns Hopkins Hosp. 1962;3(111):89–97.
Young LH, Appen RE. Ischemic oculopathy: a manifestation of carotid artery disease. Arch Neurol. 1981;38:358–61.
Brown GC, Magargel LE. The ocular ischemic syndrome: clinical, fluorescein angiographic and carotid angiographic features. Int Ophthalmol. 1988;11:239–51.
Guo T, Zhang HR. Clinical features and carotid color ultrasonic Doppler characteristics of ocular ischemic syndrome. Chin J Ophthalmol. 2011;47:228–34.
Paraskevas KI, Mikhailidis DP, Liapis CD. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors. Angiology. 2007;58:329–35.
Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome. Surv Ophthalmol. 2010;55:2–34.
Wu ZY, Yang HS, Li XM. The application of color Doppler ultrasound system in intraocular lesions. Chin J Ophthalmol. 1997;33:88–90.
Havelius U, Bergqvist D, Hindfelt B, et al. Improved dark adaptation after carotid endarterectomy: evidence of a long-term ischemic penumbra. Neurology. 1997;49:1360–4.
Costa VP, Kuzniec S, Molnar LJ, et al. The effects of carotid endarterectomy on the retrobulbar circulation of patients with severe occlusive carotid artery disease. Ophthalmology. 1999;106:306–10.
Wolintz RJ. Carotid endarterectomy for ophthalmic manifestations: is it ever indicated? J Neuroophthalmol. 2005;25:299–302.
Liu SR, Luo RJ, Li XM, et al. Clinical features of carotid stenosis with ocular ischemic manifestations and therapeutic effects. Chin J Ocular Fundus Dis. 2010;26:310–3.
Mizener JB, Podhajsky P, Hayreh SS. Ocular ischemic syndrome. Ophthalmology. 1997;104:859–64.
Chen KJ, Chen SN, Kao LY, et al. Ocular ischemic syndrome. Chang Gung Med J. 2001;24:483–91.
Sharma A, Sharp DM, Walker LG, et al. Colorectal MDTs: the team’s perspective. Colorectal Dis. 2007;10:63–8.
Qian YP. Preliminary experience of our hospital in one-stop outpatient services. Chin J Hosp Admin. 2003;19:437.
Winterkorn JM, Beckman RL. Recovery from ocular ischemic syndrome after treatment with verapamil. J Neuroophthalmol. 1995;15:209–11.
Kozobolis VP, Detorakis ET, Georgiadis GS, et al. Perimetric and retrobulbar blood flow changes following carotid endarterectomy. Graefes Arch Clin Exp Ophthalmol. 2007;245:1639–45.
Gross R. Neovascular glaucoma and ocular ischemic syndrome. J Glaucoma. 2000;9:409–12.
Sivak-Callcott JA, O’Day DM, Gass JD, et al. Evidence based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108:1767–76.
Zhao L, Wang YL. Establishment and application of access database of chronic diseases. J Trad Chin Ophthalmol. 2010;20:241–3.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd. and People's Medical Publishing House, PR of China
About this chapter
Cite this chapter
Wang, Y., Feng, Y. (2020). The Establishment of Interdisciplinary Comprehensive Diagnosis Model for Ocular Ischemia Syndrome. In: Wang, N. (eds) Integrative Ophthalmology. Advances in Visual Science and Eye Diseases, vol 3. Springer, Singapore. https://doi.org/10.1007/978-981-13-7896-6_22
Download citation
DOI: https://doi.org/10.1007/978-981-13-7896-6_22
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7895-9
Online ISBN: 978-981-13-7896-6
eBook Packages: MedicineMedicine (R0)